Fully Human Antibody Targeting Human CD123 For Cancer Threpeutics Development
Technology
E-131-2018
Patent ID
E-131-2018-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
62/734,106
IC
NCI
Date Filed
Date Issued
Patent PDF